Phibro Animal Health (PAHC) Capital Expenditures Growth (1y) (2014 - 2026)
Phibro Animal Health (PAHC) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | -21.54% |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | -431.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -431.11% |
| Dec 31, 2025 | 217.03% |
| Sep 30, 2025 | -98.90% |
| Jun 30, 2025 | 0.54% |
| Mar 31, 2025 | -20.40% |
| Dec 31, 2024 | -57.13% |
| Sep 30, 2024 | 4,917.28% |
| Jun 30, 2024 | 20.03% |
| Mar 31, 2024 | -76.80% |
| Dec 31, 2023 | 175.35% |
| Sep 30, 2023 | -99.18% |
| Jun 30, 2023 | 149.06% |
| Mar 31, 2023 | 318.75% |
| Dec 31, 2022 | -414.84% |
| Sep 30, 2022 | 211.13% |
| Jun 30, 2022 | -9.21% |
| Mar 31, 2022 | -55.14% |
| Dec 31, 2021 | 2,646.36% |
| Sep 30, 2021 | 3,533.66% |
| Jun 30, 2021 | -162.21% |